Pune, India -- (SBWIRE) -- 05/23/2019 -- The Global Esoteric Testing Market is estimated to grow at CAGR above 10 % over the forecast time frame 2019-2026 and reach the market value around USD 40 billion by 2026.

Analysis of "rare" molecules or substances is an esoteric test. It is not conducted in a clinical routine laboratory. These tests are done if additional information is required for external testing of routines for disease to be properly diagnosed, a prognosis made or a therapeutic treatment selected and supervised. Each personnel must conduct the tests and evaluate the outcomes by using sophisticated chemicals and instruments in the context of esoteric testing.

Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1379

More prevalence and increasing geriatric population highly prone to chronic conditions will drive esoteric testing markets throughout the forecast time frame and the predominance of chronic disease and infectious disease in developing countries such as China, India, etc. will support the growth.

The increasing number of people with rare diseases has increased the burden of innovative test solutions on healthcare systems to fuel industry growth. The advanced laboratory equipment that leads to a growing use of cutting-edge technologies such as flow cytometry, mass spectrometry, and real time PCR will further the growth of industry.

In the forecast period, growing awareness of the early detection of disease, together with increased demand for genomics and proteomic medicines will have a positive impact on esoteric tests. However, the absence of skilled professionals and strict regulations on esoteric testing will prevent the industry's future growth.

In 2018, esoteric testing for infectious diseases dominated the industry, with around 28 %, followed by endocrinology. This is expected to show substantial growth over the next few years. The increased incidence and demand for advanced molecular tests to identify rares in the body of infectious diseases will drive segment growth. This is increase in the number of infections. An increasing awareness about diagnosis and treatment of pre-disease in the next few years will further boost demand for esoteric tests.

View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/esoteric-testing-market

Regional Stance

Because of the increasing incidence of rare and complex diseases and the use of cutting edge technology, Germany's esoteric testing market should expand to over 9.8% CAGR. The German National Rare Disease Plan has been well developed with centralized core neonatal screening programmes, national funding, access to therapies, robust research plans, coordinated networks and cross-border rare disease cooperation, all of which will eventually boost industry growth.

By 2025, India's esoteric testing market will be led to reach USD 1.4 billion by developing its health infrastructure, increasing awareness of early disease detections, and numerous government initiatives. Initiatives such as the government's action plan to eradicate visceral leishmaniasis (VL) by 2017 will foster the growth of the industry. In addition, the increased population of elderly people in the country will boost the demand for esoteric testing in the next years.

Key Players & Strategies

Laboratory Corporation of America, BioMONTR and American Esoteric Laboratories (AEL), OPKO Health, Nordic Laboratories, Miraca Holdings, ACM, Fulgent Genetics, Genomic health, Invitae, Mayo Medical Labors, Arup Laboratories, and Myriad Genetics are few leading industry players. In order to strengthen their product offering, industry players are adopting different inorganic strategies such as acquisition, strategic partnership and collaboration, increasing their market position and business portfolio.

Esoteric testing is dominated by key players, such as Laboratory Corporation of America and Quest Diagnostics. Acquisition is one of these industry players ' main strategies. For example, in August 2017, in order to expand the oncology segment LabCorp purchased Chiltern International. More infectious diseases, increased chronic illness and increased awareness of early diagnosis have increased demand for esoteric testing. Similar strategy to broaden the product portfolio is also adopted by other players. Opko acquired the Bio-Reference Laboratory in August 2015 to advance clinical trial solutions of the company.

Browse All official Market Research Reports Press Releases@ https://www.acumenresearchandconsulting.com/press-releases

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Esoteric Testing
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Esoteric Testing Market By Test Type
1.2.2.1. Global Esoteric Testing Market Revenue and Growth Rate Comparison By Test Type (2015-2026)
1.2.2.2. Global Esoteric Testing Market Revenue Share By Test Type in 2017
1.2.2.3. Infectious Disease & Immunology
1.2.2.4. Endocrinology
1.2.2.5. Toxicology
1.2.2.6. Neurology
1.2.2.7. Oncology
1.2.2.8. Genomics
1.2.3. Esoteric Testing Market By Technology
1.2.3.1. Global Esoteric Testing Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.3.2. Global Esoteric Testing Market Revenue Share By Technology in 2017
1.2.3.3. Mass Spectrometry
1.2.3.4. Radioimmunoassay
1.2.3.5. Chemiluminescence
1.2.3.6. Flow Cytometry
1.2.3.7. Real Time-PCR
1.2.3.8. ELISA
1.2.4. Esoteric Testing Market by Geography
1.2.4.1. Global Esoteric Testing Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Esoteric Testing Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Esoteric Testing Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Esoteric Testing Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Esoteric Testing Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Esoteric Testing Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter's Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Esoteric Testing Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Esoteric Testing Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Esoteric Testing Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Esoteric Testing Major Manufacturers in 2017

CHAPTER 4. ESOTERIC TESTING MARKET BY TEST TYPE

4.1. Global Esoteric Testing Revenue By Test Type
4.2. Infectious Disease & Immunology
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Endocrinology
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Toxicology
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Neurology
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Oncology
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.7. Genomics
4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. ESOTERIC TESTING MARKET BY TECHNOLOGY

5.1. Global Esoteric Testing Revenue By Technology
5.2. Mass Spectrometry
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Radioimmunoassay
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Chemiluminescence
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Flow Cytometry
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Real Time-PCR
5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.7. ELISA
5.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA ESOTERIC TESTING MARKET BY COUNTRY

6.1. North America Esoteric Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Esoteric Testing Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Esoteric Testing Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE ESOTERIC TESTING MARKET BY COUNTRY

7.1. Europe Esoteric Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Esoteric Testing Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC ESOTERIC TESTING MARKET BY COUNTRY

8.1. Asia-Pacific Esoteric Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Esoteric Testing Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA ESOTERIC TESTING MARKET BY COUNTRY

9.1. Latin America Esoteric Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Esoteric Testing Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST ESOTERIC TESTING MARKET BY COUNTRY

10.1. Middle East Esoteric Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Esoteric Testing Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 11. AFRICA ESOTERIC TESTING MARKET BY COUNTRY

11.1. Africa Esoteric Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Esoteric Testing Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. Laboratory Corporation of America
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. BioMONTR
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. American Esoteric Laboratories (AEL)
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. OPKO Health
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Nordic Laboratories
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Miraca Holdings
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. ACM
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Fulgent Genetics
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Genomic health
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Invitae
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. Mayo Medical Labors
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies
12.12. Arup Laboratories
12.12.1. Company Snapshot
12.12.2. Overview
12.12.3. Financial Overview
12.12.4. Product Portfolio
12.12.5. Key Developments
12.12.6. Strategies
12.13. Myriad Genetics
12.13.1. Company Snapshot
12.13.2. Overview
12.13.3. Financial Overview
12.13.4. Product Portfolio
12.13.5. Key Developments
12.13.6. Strategies
12.14. Others
12.14.1. Company Snapshot
12.14.2. Overview
12.14.3. Financial Overview
12.14.4. Product Portfolio
12.14.5. Key Developments
12.14.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

INQUIRY BEFORE BUYING@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/1379

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this Premium Research Report - https://www.acumenresearchandconsulting.com/buy-now/0/1379

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.